We demonstrated that FXR signaling antagonist z-guggulsterone reduced gastric cancer cell viability through inhibiting cell proliferation, decreasing intrinsic mitochondrial apoptosis, and downregulating VEGF and TGF-β1 levels but upregulating the TNF-α level. This evidence concerns the gene VEGFA and gastric cancer.